MetLife

MET · NYSE

$101.18+$1.60 (+1.61%)TodayMarket closed ·
Prev close $99.58

About MET

MetLife, Inc. engages in providing insurance and financial services to individual and institutional customers. The company is headquartered in New York City, New York and currently employs 46,000 full-time employees. The company went IPO on 2000-04-05. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. The company operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.

Employees
46,000
Headquarters
New York City, New York
Listed
Apr 5, 2000
Sector
Financials
Industry
Insurance

MET key statistics

Market cap
63.28B
Price-earnings ratio
19.08
Dividend yield
2.62%
Average volume
3.08M
Volume
1.44M
Open price
$99.98
High today
$101.39
Low today
$99.82
52 Week high
$102.43
52 Week low
$67.33

MetLife (MET) at a glance

As of Oct 20, 2026, MetLife (MET) shares are priced at $101.18, giving the company a market cap of 63.28B, a price-to-earnings ratio of 19.08 and a dividend yield of 2.62%.

Today the stock has traded between $99.82 and $101.39. The current price is 1.4% above the day's low and 0.2% below its high.

Volume so far is 1.44M shares, below the average of 3.08M shares a day.

Over the past year MetLife has ranged from $67.33 to $102.43, and now sits 96% of the way up that range.

MetLife met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $2.43 per share against an estimate of $2.32.

The average analyst price target is $105.41, 4.2% above the current price, from 16 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

88%of 16 analyst ratings say Buy
  • Buy87.5%
  • Hold12.5%
  • Sell0.0%
Price target · 19 analystsAvg $105.41
Low
$73.92
Now
$101.18
High
$124.95

MET earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 5.2% on average.

  1. Q3 FY24: reported $1.95 per share against an estimate of $2.19
  2. Q4 FY24: reported $2.08 per share against an estimate of $2.12
  3. Q1 FY25: reported $1.96 per share against an estimate of $2.02
  4. Q2 FY25: reported $2.02 per share against an estimate of $2.17
  5. Q3 FY25: reported $2.37 per share against an estimate of $2.34
  6. Q4 FY25: reported $2.58 per share against an estimate of $2.37
  7. Q1 FY26: reported $2.42 per share against an estimate of $2.29
  8. Q2 FY26: reported $2.43 per share against an estimate of $2.32

MET news

  • Press releaseBusiness Wire

    MetLife Brings Pet Insurance to ChatGPT, Expanding How Consumers Research, Quote and Fetch Coverage Through AI

  • Press releaseBusiness Wire

    MetLife to Announce Third Quarter 2026 Results

  • Press releaseBusiness Wire

    A Record 95% of Sponsors With De-Risking Goals Intend to Fully Divest Their Pension Liabilities, MetLife Poll Finds

  • Press releaseBusiness Wire

    MetLife Declares Fourth Quarter 2026 Common Stock Dividend

  • 'Prudential Mexico, Brazil Units Draw Interest from MetLife, CNP' - Bloomberg

  • Press releasePRNewswire

    Octane Closes $1.4 Billion Forward-Flow Deal with New York Life, MetLife Investment Management, Equitable, Pacific Life, and Victory Park Capital

  • Press releaseBusiness Wire

    MetLife Investment Management Closes Galaxy 38 CLO

  • Crispus Nyaga

    US Debt is Nearing $40.1 Trillion: Top Three Stock Sectors Set to Benefit

Similar companies

Companies in the same industry as MetLife

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.